Real-World Evidence for Control of Patients With Chronic Migraine Who Received Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody Therapy Added to OnabotulinumtoxinA Treatment

被引：0

作者：

Blumenfeld, Andrew M. ^{[1
]}

Frishberg, Benjamin M. ^{[1
]}

Schim, Jack D. ^{[1
]}

Iannone, Ashley ^{[2
]}

Yedigarova, Larisa ^{[3
]}

Adams, Aubrey Manack ^{[3
]}

机构：

[1] Headache Ctr Southern California, Neurol Ctr, Irvine, CA USA

[2] ICON plc, Dublin, Ireland

[3] AbbVie Co, Allergan, Lake Bluff, IL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

1426

引用

页数：4